Physician profile
Aaron T Jones
NPI 1861622862
$9,770.28
in general payments reported to CMS, 2019-2025
53 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,168 · 2020: $1,191 · 2021: $1,475 · 2022: $1,440 · 2023: $1,442 · 2024: $1,050 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,496.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,452.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,017.69 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,001.26 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $866.92 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $849.64 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $540.88 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Sanofi-Aventis U.S. LLC | $437.47 | 2019-2023 | |
| Abbott Laboratories | $292.32 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $276.98 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Xeris Pharmaceuticals, INC. | $232.34 | 2021-2025 | Gvoke Hypopen |
| Amgen INC. | $218.46 | 2019-2024 | Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $211.16 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $177.43 | 2019-2022 | |
| Amarin Pharma, INC. | $173.81 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $130.72 | 2023-2024 | Rexulti |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $124.88 | 2019-2025 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $123.92 | 2020-2021 | |
| Abiomed | $109.52 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.28 | 2022-2024 | |
| Genentech USA, INC. | $102.38 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $99.90 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $98.58 | 2023-2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $97.53 | 2023-2025 | Voquezna |
| Allergan, INC. | $79.11 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.18 | 2019-2022 | |
| Inspire Medical Systems, INC. | $72.94 | 2023-2024 | Inspire |
| Astellas Pharma US INC | $63.97 | 2021-2025 | Veozah |
| Eisai INC. | $57.20 | 2020 | |
| Dexcom, INC. | $53.49 | 2021-2023 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $41.97 | 2019-2021 | |
| Baxter Healthcare | $41.04 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.29 | 2019 | |
| Merz Pharmaceuticals, LLC | $37.28 | 2021 | |
| Merz North America, INC. | $36.51 | 2019 | |
| Esperion Therapeutics, INC. | $34.77 | 2021-2022 | |
| Dynavax Technologies Corporation | $34.59 | 2025 | Heplisav-B |
| Antares Pharma, INC. | $33.40 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Kyowa Kirin, INC. | $30.17 | 2024 | Crysvita |
| Daiichi Sankyo INC. | $29.71 | 2019-2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $27.89 | 2021-2022 | |
| Verona Pharma, INC. | $24.37 | 2025 | Ohtuvayre |
| Acadia Pharmaceuticals INC | $22.99 | 2023 | Daybue |
| Stryker Corporation | $20.48 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $20.38 | 2021 | |
| Silk Road Medical, INC. | $20.13 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Vanda Pharmaceuticals INC. | $19.91 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.21 | 2024 | Quviviq |
| Regeneron Healthcare Solutions, INC. | $17.99 | 2024 | Dupixent |
| Nevro Corp. | $17.94 | 2022 | |
| Axsome Therapeutics, INC. | $17.06 | 2025 | Auvelity |
| Collegium Pharmaceutical, INC. | $14.11 | 2025 | Jornay Pm |
| Exact Sciences Corporation | $13.73 | 2025 | Cologuard Collection Kit |
| Radius Health, INC. | $13.46 | 2023 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.